Alps Advisors Inc Vertex Pharmaceuticals Inc Transaction History

Alps Advisors Inc

$14.5 Billion
Q2 2024

A detailed history of Alps Advisors Inc transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Alps Advisors Inc holds 2,132 shares of VRTX stock, worth $1.07 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

2,132

Previous 2,052 3.9%

Holding current value

$1.07 Million

Previous $857,000 16.57%

% of portfolio

0.01%

Previous 0.01%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$392.81 - $485.53 $31,424 - $38,842	80 Added 3.9%	2,132 $999,000
Q1 2024 May 14, 2024	SELL	$407.69 - $446.08 $118,637 - $129,809	-291 Reduced 12.42%	2,052 $857,000
Q4 2023 Feb 14, 2024	SELL	$343.0 - $410.68 $106,673 - $127,721	-311 Reduced 11.72%	2,343 $953,000
Q3 2023 Nov 14, 2023	BUY	$338.18 - $362.46 $61,886 - $66,330	183 Added 7.41%	2,654 $922,000
Q2 2023 Aug 14, 2023	BUY	$314.42 - $351.91 $263,798 - $295,252	839 Added 51.41%	2,471 $869,000
Q1 2023 May 10, 2023	SELL	$283.23 - $323.1 $281,813 - $321,484	-995 Reduced 37.88%	1,632 $514,000
Q4 2022 Feb 14, 2023	SELL	$285.76 - $321.48 $34,291 - $38,577	-120 Reduced 4.37%	2,627 $758,000
Q3 2022 Nov 14, 2022	BUY	$273.83 - $305.53 $112,544 - $125,572	411 Added 17.59%	2,747 $795,000
Q2 2022 Aug 11, 2022	BUY	$234.96 - $292.55 $22,791 - $28,377	97 Added 4.33%	2,336 $658,000
Q1 2022 May 16, 2022	SELL	$221.42 - $260.97 $175,364 - $206,688	-792 Reduced 26.13%	2,239 $584,000
Q4 2021 Feb 09, 2022	SELL	$177.01 - $223.45 $62,661 - $79,101	-354 Reduced 10.46%	3,031 $666,000
Q3 2021 Nov 15, 2021	BUY	$181.39 - $202.99 $292,763 - $327,625	1,614 Added 91.13%	3,385 $614,000
Q2 2021 Aug 11, 2021	SELL	$187.49 - $221.1 $11,811 - $13,929	-63 Reduced 3.44%	1,771 $357,000
Q1 2021 May 07, 2021	SELL	$207.02 - $241.31 $296,452 - $345,555	-1,432 Reduced 43.85%	1,834 $394,000
Q4 2020 Feb 03, 2021	SELL	$207.01 - $276.09 $56,306 - $75,096	-272 Reduced 7.69%	3,266 $772,000
Q3 2020 Nov 04, 2020	BUY	$255.65 - $303.1 $338,224 - $401,001	1,323 Added 59.73%	3,538 $963,000
Q2 2020 Aug 05, 2020	BUY	$225.48 - $295.8 $259,076 - $339,874	1,149 Added 107.79%	2,215 $643,000
Q1 2020 May 06, 2020	SELL	$199.77 - $247.81 $183,988 - $228,233	-921 Reduced 46.35%	1,066 $254,000
Q4 2019 Feb 07, 2020	SELL	$166.71 - $223.91 $14,503 - $19,480	-87 Reduced 4.19%	1,987 $435,000
Q3 2019 Nov 04, 2019	SELL	$166.23 - $187.09 $3,490 - $3,928	-21 Reduced 1.0%	2,074 $351,000
Q2 2019 Aug 07, 2019	SELL	$164.61 - $190.37 $18,436 - $21,321	-112 Reduced 5.07%	2,095 $384,000
Q1 2019 May 01, 2019	BUY	$163.73 - $194.7 $361,352 - $429,702	2,207 New	2,207 $406,000

Others Institutions Holding VRTX

# of Institutions

1,716

Shares Held

225M

Call Options Held

1.19M

Put Options Held

1.56M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $129B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alps Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Alps Advisors Inc with notifications on news.

Account

Alps Advisors Inc Vertex Pharmaceuticals Inc Transaction History